| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 1694 |
| 1 | PEMBROLIZUMAB | 1670 |
| 2 | NIVOLUMAB | 1442 |
| 3 | HYDROCORTISONE | 1143 |
| 4 | HYDROCORTISONE ACETATE | 987 |
| 5 | IPILIMUMAB | 955 |
| 6 | HYDROCORTISONE CREAM | 941 |
| 7 | ANTI ITCH | 939 |
| 8 | ANTI-ITCH | 939 |
| 9 | ANTI-ITCH CREAM | 939 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 142 | 0.5420 |
| 1 | MITOTANE | 134 | 0.0732 |
| 2 | OSILODROSTAT | 142 | 0.0641 |
| 3 | ANAKINRA | 529 | 0.0313 |
| 4 | HYDROCORTISONE SODIUM SUCCINATE | 104 | 0.0261 |
| 5 | IPILIMUMAB | 955 | 0.0218 |
| 6 | TREMELIMUMAB | 93 | 0.0210 |
| 7 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 438 | 0.0179 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 148 | 0.0177 |
| 9 | MEGESTROL ACETATE | 66 | 0.0169 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 4048 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1446 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1423 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1043 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 988 |
| 5 | Platinum-based Drug [EPC] | 911 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 902 |
| 7 | Proton Pump Inhibitor [EPC] | 769 |
| 8 | Vitamin C [EPC] | 651 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 645 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 45 | 0.0450 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 529 | 0.0313 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 15 | 0.0228 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1043 | 0.0216 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1446 | 0.0147 |
| 5 | Melanocortin 4 Receptor Agonist [EPC] | 4 | 0.0140 |
| 6 | Adrenocorticotropic Hormone [EPC] | 11 | 0.0123 |
| 7 | Cyclooxygenase Inhibitor [EPC] | 1 | 0.0122 |
| 8 | Bispecific HER2-directed Antibody [EPC] | 1 | 0.0122 |
| 9 | Human Immunoglobulin G [EPC] | 231 | 0.0110 |